GlaxoSmithKline sells off $155M Zantac plant in India to Hetero Labs for a fraction of its cost

GlaxoSmithKline sells off $155M Zantac plant in India to Hetero Labs for a fraction of its cost
kdunleavy
Wed, 03/31/2021 – 10:38